Home » Clinical Trials » Search Clinical Trials Therapeutic Areas: Endocrinology | Family Medicine
Diabetes Mellitus, Type 1 Clinical Trials
A listing of Diabetes Mellitus, Type 1 medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 4 5 6 7 Last
Alabama
Novo Nordisk Clinical Trial Call Center
Updated
A Phase 3 clinical study for patients with Diabetes or Diabetes Mellitus, Type 1
Arizona
University of Arizona
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
California
Anaheim Clinical Trials (ACT)
Patients with Type I Diabetes needed for a clinical research trial.
AMCR Institute, Inc.
A 52- Week Study to Compare the Glycemic Effects, Safety and Tolerability of A 52- Week Study to Evaluate the Safety and Efficacy of CBX129801 in Patients with Type 1 Diabetes With Mild to Moderate Diabetic Peripheral Neuropathy
AMCR Institute, Inc.
A Comparison of the Study Medication Once Daily at a Fixed Time to the Study Medication at a Variable Time in Patients With Diabetes Mellitus Type 1
AMCR Institute, Inc.
Evaluation of Metabolic Outcomes and Safety of Hylenex Recombinant Used as Pre-administration Infusion Site Treatment in Patients With Diabetes Mellitus Type 1 on Insulin Pump
AMCR Institute, Inc.
The Natural History Study of the development of Type 1 Diabetes Screening Blood Test to Identify Increased Risk of Diabetes Mellitus Type 1
Children’s Hospital of Los Angeles
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
UCSD Rady Children’s Hospital
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
View More »
Novo Nordisk Clinical Trial Call Center
Updated
A Phase 3 clinical study for patients with Diabetes or Diabetes Mellitus, Type 1
Profil Institute for Clinical Research, Inc.
A clinical trial seeking patients for a research study for the treatment of Healthy, Type 1 Diabetes Mellitus or Type 2 Diabetes Mellitus
Novo Nordisk Clinical Trial Call Center
Updated
A Phase 3 clinical study for patients with Diabetes or Diabetes Mellitus, Type 1
For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Escondido California 92026
A clinical trial to evaluate treatments using CBX129801 for patients with Diabetic Peripheral Neuropathy
Novo Nordisk Clinical Trial Call Center
Updated
A Phase 3 clinical study for patients with Diabetes or Diabetes Mellitus, Type 1
For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Fresno California 93720
A clinical trial to evaluate treatments using CBX129801 for patients with Diabetic Peripheral Neuropathy
Novo Nordisk Clinical Trial Call Center
Updated
A Phase 3 clinical study for patients with Diabetes or Diabetes Mellitus, Type 1
For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Irvine California 92618
A clinical trial to evaluate treatments using CBX129801 for patients with Diabetic Peripheral Neuropathy
For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Novo Nordisk Clinical Trial Call Center
Updated
A Phase 3 clinical study for patients with Diabetes or Diabetes Mellitus, Type 1
Novo Nordisk Clinical Trial Call Center
Updated
A Phase 3 clinical study for patients with Diabetes or Diabetes Mellitus, Type 1
Diabetes Care Center
A clinical trial to evaluate treatments using Lispro Insulin and glargine insulin for patients with Diabetes Mellitus Type 1
Accelovance Inc.
A clinical study for patients with Insulin Dependent Diabetes, Non Insulin Dependent Diabetes or Gestational Diabetes
San Diego California 92161
A clinical trial to evaluate treatments using CBX129801 for patients with Diabetic Peripheral Neuropathy
San Francisco California 94110
A clinical trial to evaluate treatments using CBX129801 for patients with Diabetic Peripheral Neuropathy
For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Stanford University and Stanford Hospital & Clinics
Patients are needed to participate in a clinical research study evaluating TTR controller (Medtronic) for the treatment of Diabetes Mellitus, Type 1 Diabetes or Metabolic and Nutritional Disorders
Torrance California 90502
A clinical trial to evaluate treatments using CBX129801 for patients with Diabetic Peripheral Neuropathy
Tustin California 92780
A clinical trial to evaluate treatments using CBX129801 for patients with Diabetic Peripheral Neuropathy
Novo Nordisk Clinical Trial Call Center
Updated
A Phase 3 clinical study for patients with Diabetes or Diabetes Mellitus, Type 1
Walnut Creek California 94598
A clinical trial to evaluate treatments using CBX129801 for patients with Diabetic Peripheral Neuropathy
Novo Nordisk Clinical Trial Call Center
Updated
A Phase 3 clinical study for patients with Diabetes or Diabetes Mellitus, Type 1
Colorado
University of Colorado, Barbara Davis Center for Childhood Diabetes
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Lexicon Investigational Site
A Phase 2 clinical study for patients with Type 1 Diabetes Mellitus
For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Subjects With Type 1 Diabetes (T1DM)
Barbara Davis Center
Pramlintide in Adolescents With Type 1 Diabetes
Novo Nordisk Clinical Trial Call Center
Updated
A Phase 3 clinical study for patients with Diabetes or Diabetes Mellitus, Type 1
Delaware
Alfred I duPont Hospital
A clinical research study of Atorvastatin and Atorvastatin Placebo for the treatment of Diabetes Mellitus, Insulin-Dependent or Hypercholesterolemia
First 1 2 3 4 5 6 7 Last
